BGM: Qilian International Holding Group Limited Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 45.05
Enterprise Value ($M) 36.19
Book Value ($M) 44.92
Book Value / Share 6.28
Price / Book 1.00
NCAV ($M) 28.40
NCAV / Share 3.97
Price / NCAV 1.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.18

Liquidity (mrq)
Quick Ratio 6.06
Current Ratio 7.05

Balance Sheet (mrq) ($M)
Current Assets 33.33
Assets 49.85
Liabilities 4.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-13 1,951 16,083 12.13
2024-09-12 900 8,471 10.62
2024-09-11 210 3,830 5.48
2024-09-10 3 4,165 0.07

(click for more detail)

Similar Companies
BCTX – BriaCell Therapeutics Corp. BFRG – Bullfrog AI Holdings, Inc.
BFRI – Biofrontera Inc. BGXX – Bright Green Corporation
BIVI – BioVie Inc.


Financial data and stock pages provided by
Fintel.io